Centuple Global Limited

₹30.98As of Sun 8 Nov 2026, 12:00 UTC
BSE:531099Healthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR 36.67%
Div yield —
ROE 12.67%
Drugs, Drug Proprietaries, and Druggists' Sundries
Beta (5Y) 0.28
PE TTM 13.72
TSR TTM (54.59%)
Mkt cap ₹169.4M
ROIC 4.13%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹36
15.28%
(78.25%)
Hold 3|1|11|5|4
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
0.81
0.88
0.96
0.96
31.34%
30.92%
28.77%
25.65%
Revenue₹M
11.73
11.48
11.65
11.63
9.97%
3.02%
3.45%
1.55%
Peers (US$1.878M)
Cap (US$)
PE
1.851M
6.212x
Capital
TTM
5Y
10Y
Leveragex
2.141
(0.911)
(0.695)
EBIT/Intx
1.524
0.262
0.272
Own earn%
220.31
78.92
68.48
Sh yield%
40.19
55.43
53.82
Owners
Insiders/Inst%
8.64
63.20
Short interest%
2.25
SBC / revenue%
0.87
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
13–17
$1 testx
—
Incr. ROIC%
0